B

Active Director Director DIN 08443532
DIN 08443532 First appointment May 2019 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2019
Shareholding value •••• Premium profile

About Bhawana

Data last updated:

Bhawana is a Director at Ryokona Pharmaceuticals Private Limited (since 2019). The company operates in Chemicals. Ryokona Pharmaceuticals Private Limited reported revenue of ₹13.6 Lakh (FY 2025).

DIN 08443532
Primary Designation Director
Industry Chemicals
First Appointment 04 May 2019
Oldest Company Age 10 yrs
Largest company Ryokona Pharmaceuticals Private Limited · ₹13.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 May 20192016₹13.6 Lakh (FY 2025)Active

Board colleagues of Bhawana

NameDINCompanyDesignation
Ajit Singh07574884Ryokona Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ryokona Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Bhawana

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhawana

Bhawana currently holds 1 directorship: Ryokona Pharmaceuticals Private Limited (Director, since 04 May 2019, revenue ₹13.6 Lakh (FY 2025)).

Bhawana was first appointed on 04 May 2019 as Director at Ryokona Pharmaceuticals Private Limited.

The current boards of Bhawana's companies include Ajit Singh (Ryokona Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available